TL Holland… - Journal of Infectious Diseases, 2011 - jid.oxfordjournals.org For decades, vancomycin has been the mainstay of treatment for serious methicillin-resistant Staphylococcus aureus (MRSA) infections. Recently, a debate has arisen over its continued utility for this purpose [1], fueled by a steady stream of reports linking a worse clinical ... Related articles - All 2 versions
R Kullar, SL Davis, DP Levine… - Clinical Infectious …, 2011 - cid.oxfordjournals.org Correspondence: Michael J. Rybak, PharmD, MPH, Anti-Infective Research Laboratory, Dept of Pharmacy Practice, College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Ave, Detroit, MI 48201 (m.rybak{at}wayne.edu). ... (See the article by Patel et al, on ... Cited by 3 - Related articles - All 4 versions
K Chotikanatis, M Backer… - Journal of Clinical …, 2011 - Am Soc Microbiol Page 1. 0 Recurrent intravascular catheter-related bacteremia caused by Delftia 1 acidovorans in a hemodialysis patient 2 3 ... Page 2. 1 Abstract 20 We report the first case of recurrent intravascular catheter-related bacteremia in 21 ...
S Lee, PG Choe, KH Song, SW Park… - Antimicrobial Agents …, 2011 - Am Soc Microbiol Page 1. 1 Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible 1 Staphylococcus aureus bacteremia? 2 3 ... College of Medicine, Seoul, Republic of Korea 8 9 Running title: Cefazolin for treatment of MSSA bacteremia 10 11 12 13 ...
F Palacio, JS Lewis, L Sadkowski… - Antimicrobial Agents …, 2011 - Am Soc Microbiol We describe a case of Streptococcus anginosus with resistance to daptomycin associated with breakthrough S. anginosus bacteremia in a 47-year-old male receiving 6 mg/kg of body weight/day of daptomycin. The patient had an extensive past medical history that included ... Related articles - All 3 versions